York-based international animal health business Animalcare Group plc published on Thursday an unaudited trading update for the year ended December 31, 2025, “delivering strong revenue and underlying EBITDA growth, in line with market expectations.”

Animalcare said revenue rose 20% to approximately £89.1 million.

Animalcare said it believes that consensus market expectations for the year ended December 31, 2025, is for revenue of £89.2 million and underlying EBITDA after R&D costs of £17.6 million.

“Following a strong 2025 performance, Animalcare has entered 2026 with positive momentum,” said the York firm.

“The group continues to optimise its portfolio and seek opportunities to leverage and efficiently scale its commercial platform, which alongside developing its innovative pipeline and selective M&A activity, will position the company for accelerated sustainable growth.”

Animalcare CEO Jenny Winter said: “2025 was a year of strong delivery for Animalcare, marked by the successful integration of Randlab, double-digit growth in our flagship brands and disciplined investment in our exciting development pipeline.

“We are increasingly well positioned to address the evolving demands of the growing global veterinary market and see considerable opportunity to accelerate growth rates through our three-pillar growth strategy.

“With a strong balance sheet, a scalable commercial platform and increasing market presence, we look to the future with confidence.”